| Jeffrey M Ventre, MD | |
|
1470 N 16th Ave, Yakima, WA 98902-1381 | |
| (509) 574-6000 | |
| (509) 225-2714 |
| Full Name | Jeffrey M Ventre |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 16 Years |
| Location | 1470 N 16th Ave, Yakima, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487815213 | NPI | - | NPPES |
| 0293456 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | MD60268782 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virginia Mason Memorial | Yakima, WA | Hospital |
| Kittitas Valley Community Hospital | Ellensburg, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Yakima Valley Memorial Physicians | 1557391596 | 250 |
News Archive
When accidents that involve traumatic brain injuries occur, a speedy diagnosis followed by the proper treatment can mean the difference between life and death. A research team, led by Jason D. Riley in the Section on Analytical and Functional Biophotonics at the U.S. National Institutes of Health, has created a handheld device capable of quickly detecting brain injuries such as hematomas, which occur when blood vessels become damaged and blood seeps out into surrounding tissues where it can cause significant and dangerous swelling.
Avita Medical Ltd., a regenerative medicine company specializing in the treatment of wounds and skin defects, today announced that doctors in Taiwan have reported positive results from using ReCell® to treat burn victims of June's waterpark disaster, with medics saying they have seen superior wound closure and better outcomes.
For years, scientists have attempted to understand how Alzheimer's disease harms the brain before memory loss and dementia are clinically detectable. Most researchers think this preclinical stage, which can last a decade or more before symptoms appear, is the critical phase when the disease might be controlled or stopped, possibly preventing the failure of memory and thinking abilities in the first place.
The application of nanotechnology in the field of drug delivery has attracted much attention in recent years. In cancer research, nanotechnology holds great promise for the development of targeted, localized delivery of anticancer drugs, in which only cancer cells are affected.
While scientists have known for years that African trypanosomes cause sleeping sickness, they've been left scratching their heads as to how these tiny single-celled organisms communicate. A University of Georgia study, published Jan. 14 in the journal Cell, helps solve this mystery.
› Verified 1 days ago
| Entity Name | Yakima Valley Memorial Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306933940 PECOS PAC ID: 1557391596 Enrollment ID: O20050818000714 |
News Archive
When accidents that involve traumatic brain injuries occur, a speedy diagnosis followed by the proper treatment can mean the difference between life and death. A research team, led by Jason D. Riley in the Section on Analytical and Functional Biophotonics at the U.S. National Institutes of Health, has created a handheld device capable of quickly detecting brain injuries such as hematomas, which occur when blood vessels become damaged and blood seeps out into surrounding tissues where it can cause significant and dangerous swelling.
Avita Medical Ltd., a regenerative medicine company specializing in the treatment of wounds and skin defects, today announced that doctors in Taiwan have reported positive results from using ReCell® to treat burn victims of June's waterpark disaster, with medics saying they have seen superior wound closure and better outcomes.
For years, scientists have attempted to understand how Alzheimer's disease harms the brain before memory loss and dementia are clinically detectable. Most researchers think this preclinical stage, which can last a decade or more before symptoms appear, is the critical phase when the disease might be controlled or stopped, possibly preventing the failure of memory and thinking abilities in the first place.
The application of nanotechnology in the field of drug delivery has attracted much attention in recent years. In cancer research, nanotechnology holds great promise for the development of targeted, localized delivery of anticancer drugs, in which only cancer cells are affected.
While scientists have known for years that African trypanosomes cause sleeping sickness, they've been left scratching their heads as to how these tiny single-celled organisms communicate. A University of Georgia study, published Jan. 14 in the journal Cell, helps solve this mystery.
› Verified 1 days ago
| Entity Name | Memorial Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962938183 PECOS PAC ID: 4789733494 Enrollment ID: O20100602000561 |
News Archive
When accidents that involve traumatic brain injuries occur, a speedy diagnosis followed by the proper treatment can mean the difference between life and death. A research team, led by Jason D. Riley in the Section on Analytical and Functional Biophotonics at the U.S. National Institutes of Health, has created a handheld device capable of quickly detecting brain injuries such as hematomas, which occur when blood vessels become damaged and blood seeps out into surrounding tissues where it can cause significant and dangerous swelling.
Avita Medical Ltd., a regenerative medicine company specializing in the treatment of wounds and skin defects, today announced that doctors in Taiwan have reported positive results from using ReCell® to treat burn victims of June's waterpark disaster, with medics saying they have seen superior wound closure and better outcomes.
For years, scientists have attempted to understand how Alzheimer's disease harms the brain before memory loss and dementia are clinically detectable. Most researchers think this preclinical stage, which can last a decade or more before symptoms appear, is the critical phase when the disease might be controlled or stopped, possibly preventing the failure of memory and thinking abilities in the first place.
The application of nanotechnology in the field of drug delivery has attracted much attention in recent years. In cancer research, nanotechnology holds great promise for the development of targeted, localized delivery of anticancer drugs, in which only cancer cells are affected.
While scientists have known for years that African trypanosomes cause sleeping sickness, they've been left scratching their heads as to how these tiny single-celled organisms communicate. A University of Georgia study, published Jan. 14 in the journal Cell, helps solve this mystery.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey M Ventre, MD 1470 N 16th Ave, Yakima, WA 98902-1381 Ph: (509) 574-6000 | Jeffrey M Ventre, MD 1470 N 16th Ave, Yakima, WA 98902-1381 Ph: (509) 574-6000 |
News Archive
When accidents that involve traumatic brain injuries occur, a speedy diagnosis followed by the proper treatment can mean the difference between life and death. A research team, led by Jason D. Riley in the Section on Analytical and Functional Biophotonics at the U.S. National Institutes of Health, has created a handheld device capable of quickly detecting brain injuries such as hematomas, which occur when blood vessels become damaged and blood seeps out into surrounding tissues where it can cause significant and dangerous swelling.
Avita Medical Ltd., a regenerative medicine company specializing in the treatment of wounds and skin defects, today announced that doctors in Taiwan have reported positive results from using ReCell® to treat burn victims of June's waterpark disaster, with medics saying they have seen superior wound closure and better outcomes.
For years, scientists have attempted to understand how Alzheimer's disease harms the brain before memory loss and dementia are clinically detectable. Most researchers think this preclinical stage, which can last a decade or more before symptoms appear, is the critical phase when the disease might be controlled or stopped, possibly preventing the failure of memory and thinking abilities in the first place.
The application of nanotechnology in the field of drug delivery has attracted much attention in recent years. In cancer research, nanotechnology holds great promise for the development of targeted, localized delivery of anticancer drugs, in which only cancer cells are affected.
While scientists have known for years that African trypanosomes cause sleeping sickness, they've been left scratching their heads as to how these tiny single-celled organisms communicate. A University of Georgia study, published Jan. 14 in the journal Cell, helps solve this mystery.
› Verified 1 days ago
Henry Yunwoong Kim, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1460 N 16th Ave, Suite D, Yakima, WA 98902 Phone: 509-574-3805 | |
Michael Sean Mullin, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1470 N 16th Ave, Yakima, WA 98902 Phone: 509-574-6000 Fax: 509-225-2714 | |
Marjorie L Henderson, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 508 S 4th Ave, Yakima, WA 98902 Phone: 509-574-6139 Fax: 509-574-6138 | |
Carlee Renee Gibbons, DO Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1470 N 16th Ave Ste D, Yakima, WA 98902 Phone: 509-746-3055 | |
Daniel M Kwon, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1470 N 16th Ave, Yakima, WA 98902 Phone: 509-575-6000 Fax: 509-225-2714 |